• Phosphatase Inhibitor Cocktail 100X: Advanced Strategies ...

  2025-09-28

  Explore how the Phosphatase Inhibitor Cocktail 100X uniquely preserves protein phosphorylation for complex applications like kinase activity assays and mass spectrometry. This in-depth analysis highlights advanced sample preparation strategies and integrates new insights from stem cell and DNA repair research.

• GSK343: Advancing Epigenetic Cancer Research via Selectiv...

  2025-09-27

  Discover how GSK343, a potent selective EZH2 inhibitor, is transforming epigenetic cancer research by targeting the PRC2 pathway and histone H3K27 trimethylation. This in-depth analysis explores its unique mechanism, scientific relevance, and emerging applications.

• Rucaparib (AG-014699): Advanced Mechanisms in PARP1 Inhib...

  2025-09-26

  Discover the unique mechanisms of Rucaparib (AG-014699, PF-01367338) as a potent PARP inhibitor in DNA damage response research. This article explores how Rucaparib integrates PARP1 inhibition, radiosensitization in PTEN-deficient cancer models, and novel apoptotic pathways, providing deeper insights for cancer biology research.

• Berberine (CAS 2086-83-1): Novel Insights into Inflammati...

  2025-09-25

  Explore how Berberine, a potent AMPK activator and isoquinoline alkaloid, uniquely intersects metabolic regulation with advanced inflammasome modulation. This article provides a scientific deep dive into Berberine’s mechanisms in inflammation and metabolic disease research, revealing novel therapeutic strategies.

• Redefining mRNA Functional Studies: EZ Cap™ EGFP mRNA (5-...

  2025-09-24

  Discover how EZ Cap EGFP mRNA 5-moUTP elevates immune research and in vivo imaging through advanced capping, 5-moUTP modification, and immune suppression. This article uniquely explores the intersection of enhanced green fluorescent protein mRNA and next-generation immunotherapy strategies.

• EZ Cap™ Firefly Luciferase mRNA: Cap 1 Engineering for Ad...

  2025-09-23

  Explore the impact of Cap 1 structure engineering in EZ Cap™ Firefly Luciferase mRNA for enhanced transcription efficiency, stability, and translation in molecular biology applications. This article provides a rigorous analysis of current delivery systems and practical guidance for optimizing reporter assays using capped mRNA.

• br Exocytosis of GLUT by autophagy

  2025-04-22

  

  Exocytosis of GLUT4 by autophagy Conclusion Conflict of interest Ethics statement Antigen processing and presentation Adaptive immune response has to be instructed to identify and eliminate specific pathogens or foreign entities defined by their antigenic determinants. Processed antig

• Roles of Aurora kinases in directly activating

  2025-04-22

  

  Roles of Aurora kinases in directly activating multiple oncogenic pathways and promoting proliferation as well as transformation have also been demonstrated. Aurora-A has been shown to up-regulate telomerase reverse transcriptase mRNA through c-myc [26]. The kinase was also implicated in activating

• br Materials and methods br Results br Discussion

  2025-04-19

  

  Materials and methods Results Discussion Numerous studies showed that Na+-K+-ATPase activity and membrane 2X Taq PCR Master Mix (with dye) were decreased in cardiac tissue subjected to IR (Belliard et al., 2013; Lee et al., 2013). In return, treatment that alleviated the progress of IR-rel

• In HepG cells compound showed inhibition of

  2025-04-19

  

  In HepG2 cells, 3X (DYKDDDDK) Peptide showed inhibition of total lipid syntheses with an IC of 8μM. A cell based Alamar Blue cytotoxicity assay was used in parallel to differentiate the effect on the inhibition of lipid synthesis versus potential cytotoxicity. Under identical incubation conditions

• In this study we found that ACL silencing is sufficient

  2025-04-18

  

  In this study, we found that ACL silencing is sufficient to impair myoblast differentiation and that this effect is accompanied by a decrease in MYOD early in the myogenic process and by a subsequent decline in fast MyHC protein Aprotinin at a later stage of differentiation (Figure 4J). Furthermore

• In clinical studies BA has been reported to promote

  2025-04-18

  

  In clinical studies, BA has been reported to promote dose-dependent LDL-C lowering effects of up to 30% as monotherapy, and up to an additional 24% when added in combination with stable statin therapy, or approximately 50% when combined with ezetimibe 109, 110, 111, 112. These effects were accompani

• Our research is the first

  2025-04-16

  

  Our research is the first to report that administration of HMW-HA is an effective strategy to defend against PM2.5-induced disruption of pulmonary epithelial barrier and lung injury, and addresses that HMW-HA restricts PM2.5-induced epithelial apoptosis through reducing oxidative stress and followin

• br Experimental procedures br Results

  2025-04-15

  

  Experimental procedures Results Discussion Although previous studies have indicated that astrocyte aromatase plays a role in nociceptive processes (O'Brien et al., 2015, Smeester et al., 2016), the mechanisms responsible for the regulation of aromatase and its involvement in nociception rem

• Since obesity appears to impact

  2025-04-14

  

  Since obesity appears to impact leptin and adiponectin levels in opposite manners, several studies have suggested that the serum adiponectin/leptin ratio may be a key parameter in indicating the relative risk of postmenopausal breast cancer (Ollberding et al, 2013, Cleary et al, 2009). Therapeutic s

16022 records 6/1069 page Previous Next First page 上5页 678910 下5页 Last page